Bio-Rad Laboratories Inc.
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
34.60%
Market Cap
5.71 Bil.
P/E Ratio
10.88
Dividend Yield
0.00 %
Earnings per Share
24.69 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 94.91 Bil. | 31.13 Bil. | 23.29 | +27.43 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 262 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:57:10 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 262.6 | 257.4 |
| PREV. DAY'S PRICE | 263 | (06/02) |
| CHANGE DAY BEFORE | -1.00 | -0.38 % |
| 52 WEEK HIGH / LOW | 291.7 (10/27) | 186.55 (06/03) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 8.20 | 7.67 | 24.69 | -60.43 | -20.18 |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 33.25 | 35.57 | 10.88 | - | - |
| PRICE - BOOK RATIO | - | - | 1.10 | 1.40 | 1.05 |
| PRICE - SALES RATIO | - | - | 3.20 | 3.61 | 3.53 |
| PRICE - CASH FLOW RATIO | - | - | 15.53 | 20.39 | 25.15 |
Master Data
| WKN | 865406 |
| ISIN | US0905722072 |
| SYMBOL | BUWA |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | BIO-RAD LABS INC.DL-,0001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 21.70 Mil. |
| MARKET CAPITALISATION | 5.71 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 3.14 % | 10.04 % | 10.00 % | -3.42 % | 34.60 % | -23.68 % | -44.28 % | 3.34 % |
| HIGH | 273.40 | 273.40 | 273.40 | 279.20 | 291.70 | 381.40 | 705.00 | 279.20 |
| LOW | 253.40 | 202.20 | 202.20 | 202.20 | 186.55 | 186.55 | 186.55 | 202.20 |
Dividend
per share
BIO-RAD LABS INC.DL-,0001 does not deliver dividend information
Company profile
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Structured products for Bio-Rad Laboratories Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.